Tag: non-clinical platform

Discover ISR Platform enhanced with AUDACY bioinformatics integration. Non-clinical local toxicity prediction for injection site reactions.

Oct

PRESS RELEASE – ImmunoSafe: ISR Platform®

By Genoskin Comments are Off ex vivo skin model, local toxicity, non-clinical platform

PRESS RELEASE - Salem, MA, USA - October 3rd, 2023 Genoskin Introduces ImmunoSafe: ISR Platform® with AUDACY - A Revolutionary Leap in Non-Clinical Local Toxicity Assessment Salem, MA, October 3rd, 2023 - Genoskin, a biotechnology company at the forefront of accelerating drug development, proudly announces the enhancement of its ISR Platform® with the integration of AUDACY, a state-of-the-art bioinformatics-based analytical

Genoskin develops and markets innovative testing tools to study the effects of pharmaceutical, cosmetic and chemical products on real, live ex vivo human skin.